COGT: Cogent Biosciences Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Cogent Biosciences Inc (COGT).
$861.60M Market Cap.
COGT Market Cap. (MRY)
COGT Shares Outstanding (MRY)
COGT Assets (MRY)
Total Assets
$327.90M
Total Liabilities
$71.61M
Total Investments
$188.91M
COGT Income (MRY)
Revenue
$0
Net Income
-$255.86M
Operating Expense
$275.94M
COGT Cash Flow (MRY)
CF Operations
-$207.79M
CF Investing
$38.28M
CF Financing
$214.45M
COGT Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $327,898,000 (4.61%) | $313,437,000 (4.20%) | $300,810,000 (29.61%) | $232,092,000 (-7.50%) |
Assets Current | $296,472,000 (9.49%) | $270,771,000 (2.19%) | $264,966,000 (19.01%) | $222,633,000 (-9.10%) |
Assets Non-Current | $31,426,000 (-26.34%) | $42,666,000 (19.03%) | $35,844,000 (278.94%) | $9,459,000 (57.54%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $256,286,000 (-0.59%) | $257,802,000 (0.81%) | $255,735,000 (19.40%) | $214,184,000 (-8.73%) |
Property Plant & Equipment Net | $26,564,000 (-12.45%) | $30,342,000 (-2.43%) | $31,099,000 (594.64%) | $4,477,000 (-5.73%) |
Cash & Equivalents | $98,165,000 (84.42%) | $53,229,000 (-62.29%) | $141,141,000 (-36.12%) | $220,939,000 (-9.24%) |
Accumulated Other Comprehensive Income | $447,000 (81.71%) | $246,000 (336.54%) | -$104,000 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $188,912,000 (-14.11%) | $219,941,000 (84.22%) | $119,390,000 (0%) | $0 (0%) |
Investments Current | $188,912,000 (-11.09%) | $212,481,000 (77.97%) | $119,390,000 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $7,460,000 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $12,013,000 (12.75%) | $10,655,000 (82.39%) | $5,842,000 (67.73%) | $3,483,000 (375.82%) |
Accumulated Retained Earnings (Deficit) | -$859,483,000 (-42.39%) | -$603,624,000 (-46.79%) | -$411,214,000 (-51.75%) | -$270,973,000 (-36.37%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $17,467,000 (-7.35%) | $18,853,000 (-4.05%) | $19,649,000 (522.79%) | $3,155,000 (-39.41%) |
Debt Current | $1,565,000 (12.91%) | $1,386,000 (-2.60%) | $1,423,000 (-38.77%) | $2,324,000 (13.26%) |
Debt Non-Current | $15,902,000 (-8.96%) | $17,467,000 (-4.16%) | $18,226,000 (2093.26%) | $831,000 (-73.66%) |
Total Liabilities | $71,612,000 (28.72%) | $55,635,000 (23.43%) | $45,075,000 (151.70%) | $17,908,000 (10.21%) |
Liabilities Current | $55,710,000 (45.96%) | $38,168,000 (42.16%) | $26,849,000 (57.22%) | $17,077,000 (30.42%) |
Liabilities Non-Current | $15,902,000 (-8.96%) | $17,467,000 (-4.16%) | $18,226,000 (2093.26%) | $831,000 (-73.66%) |
COGT Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $43,281,000 (25.91%) | $34,375,000 (31.14%) | $26,212,000 (33.48%) | $19,638,000 (12.72%) |
Research & Development Expense | $232,658,000 (33.90%) | $173,755,000 (42.86%) | $121,627,000 (117.53%) | $55,913,000 (117.24%) |
Operating Expenses | $275,939,000 (32.58%) | $208,130,000 (40.78%) | $147,839,000 (95.68%) | $75,551,000 (-16.12%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$255,859,000 (-32.98%) | -$192,410,000 (-37.20%) | -$140,241,000 (-94.04%) | -$72,273,000 (3.39%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$255,859,000 (-32.98%) | -$192,410,000 (-37.20%) | -$140,241,000 (-94.04%) | -$72,273,000 (3.39%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$255,859,000 (-32.98%) | -$192,410,000 (-37.20%) | -$140,241,000 (-94.04%) | -$72,273,000 (59.67%) |
Weighted Average Shares | $103,856,611 (30.38%) | $79,657,942 (35.61%) | $58,739,713 (51.66%) | $38,730,813 (249.52%) |
Weighted Average Shares Diluted | $103,856,611 (30.38%) | $79,657,942 (35.61%) | $58,739,713 (51.66%) | $38,730,813 (249.52%) |
Earning Before Interest & Taxes (EBIT) | -$255,859,000 (-32.98%) | -$192,410,000 (-37.20%) | -$140,241,000 (-94.04%) | -$72,273,000 (3.39%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$275,939,000 (-32.58%) | -$208,130,000 (-40.78%) | -$147,839,000 (-95.68%) | -$75,551,000 (8.09%) |
COGT Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $38,276,000 (139.13%) | -$97,824,000 (21.56%) | -$124,718,000 (-7155.26%) | -$1,719,000 (-120.42%) |
Net Cash Flow from Financing | $214,451,000 (31.13%) | $163,536,000 (-0.01%) | $163,558,000 (330.69%) | $37,976,000 (-83.64%) |
Net Cash Flow from Operations | -$207,791,000 (-35.26%) | -$153,624,000 (-29.49%) | -$118,638,000 (-101.89%) | -$58,763,000 (-63.91%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $44,936,000 (151.11%) | -$87,912,000 (-10.17%) | -$79,798,000 (-254.56%) | -$22,506,000 (-110.99%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $38,849,000 (140.88%) | -$95,028,000 (19.37%) | -$117,855,000 (0%) | $0 (0%) |
Capital Expenditure | -$573,000 (79.51%) | -$2,796,000 (59.26%) | -$6,863,000 (-299.24%) | -$1,719,000 (-637.19%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $214,252,000 (31.79%) | $162,571,000 (0.17%) | $162,296,000 (326.68%) | $38,037,000 (-71.35%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $39,740,000 (29.78%) | $30,621,000 (66.71%) | $18,368,000 (57.18%) | $11,686,000 (94.22%) |
Depreciation Amortization & Accretion | $4,351,000 (21.27%) | $3,588,000 (-38.96%) | $5,878,000 (195.23%) | $1,991,000 (176.53%) |
COGT Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -74.90% (-10.31%) | -67.90% (-27.39%) | -53.30% (-56.76%) | -34.00% (87.79%) |
Return on Average Assets (ROAA) | -63.30% (-8.95%) | -58.10% (-24.95%) | -46.50% (-47.15%) | -31.60% (79.69%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -101.80% (-1.19%) | -100.60% (32.12%) | -148.20% (-101.41%) | 10478.10% (248.61%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -4.02 (-32.66%) | -3.03 (54.64%) | -6.68 (-45.64%) | -4.59 (-561.10%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 3.36 (71.18%) | 1.96 (-37.83%) | 3.16 (97.93%) | 1.6 (193.92%) |
Debt to Equity Ratio (D/E) | 0.28 (29.17%) | 0.22 (22.73%) | 0.18 (109.52%) | 0.08 (21.74%) |
Earnings Per Share (EPS) | -1.94 (0.00%) | -1.94 (-12.14%) | -1.73 (7.49%) | -1.87 (88.44%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -2.01 (-2.14%) | -1.96 (8.10%) | -2.14 (-36.81%) | -1.56 (51.28%) |
Book Value Per Share (BVPS) | 2.47 (-23.73%) | 3.24 (-25.68%) | 4.35 (-21.27%) | 5.53 (-73.89%) |
Tangible Assets Book Value Per Share (TABVPS) | 3.16 (-19.77%) | 3.94 (-23.16%) | 5.12 (-14.54%) | 5.99 (-73.54%) |
Enterprise Value Over EBIT (EV/EBIT) | -3 (-50.00%) | -2 (60.00%) | -5 (-150.00%) | -2 (0%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -3.11 (-33.86%) | -2.32 (54.49%) | -5.11 (-153.70%) | -2.01 (-6190.62%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 5.32 (-24.98%) | 7.09 (-28.12%) | 9.87 (-24.30%) | 13.04 (-30.30%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$208,364,000 (-33.21%) | -$156,420,000 (-24.64%) | -$125,501,000 (-107.50%) | -$60,482,000 (-70.23%) |
Enterprise Value (EV) | $782,385,486 (78.31%) | $438,773,584 (-36.06%) | $686,226,097 (385.07%) | $141,469,769 (5846.23%) |
Earnings Before Tax (EBT) | -$255,859,000 (-32.98%) | -$192,410,000 (-37.20%) | -$140,241,000 (-94.04%) | -$72,273,000 (3.39%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$251,508,000 (-33.20%) | -$188,822,000 (-40.53%) | -$134,363,000 (-91.18%) | -$70,282,000 (5.14%) |
Invested Capital | $191,490,000 (-20.51%) | $240,893,000 (57.99%) | $152,469,000 (5606.28%) | -$2,769,000 (-565.63%) |
Working Capital | $240,762,000 (3.51%) | $232,603,000 (-2.32%) | $238,117,000 (15.84%) | $205,556,000 (-11.33%) |
Tangible Asset Value | $327,898,000 (4.61%) | $313,437,000 (4.20%) | $300,810,000 (29.61%) | $232,092,000 (-7.50%) |
Market Capitalization | $861,601,486 (70.14%) | $506,410,584 (-37.32%) | $807,968,097 (136.30%) | $341,921,769 (168.44%) |
Average Equity | $341,625,500 (20.64%) | $283,172,750 (7.58%) | $263,231,250 (23.73%) | $212,747,250 (230.56%) |
Average Assets | $404,490,000 (22.16%) | $331,112,500 (9.89%) | $301,322,750 (31.93%) | $228,400,750 (98.27%) |
Invested Capital Average | $251,321,500 (31.37%) | $191,306,500 (102.13%) | $94,647,250 (13821.96%) | -$689,750 (-165.01%) |
Shares | 110,461,729 (28.26%) | 86,124,249 (23.22%) | 69,893,434 (75.39%) | 39,851,022 (251.35%) |
